Appropriateness of the Direct Oral Anticoagulants Dosing in the Middle East Gulf Region

Autor:	Leen Oyoun Alsoud, Khalid Almuti, Wasim S El Nekidy, Mohamed AlJaabari, Wael Al Mahmeed, Bassam Atallah, Zohour Anouassi
Rok vydání:	2020
Předmět:	0301 basic medicine Male medicine.medical_specialty Time Factors United Arab Emirates Hemorrhage Inappropriate Prescribing 030204 cardiovascular system & hematology Logistic regression Risk Assessment Dabigatran 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine Atrial Fibrillation medicine Humans Drug Dosage Calculations Dosing Practice Patterns Physicians' Stroke Aged Retrospective Studies Pharmacology Aged 80 and over Rivaroxaban Embolic Stroke business.industry Atrial fibrillation Middle Aged medicine.disease Drug Utilization 030104 developmental biology Cross-Sectional Studies Treatment Outcome Health Care Surveys Apixaban Female Cardiology and Cardiovascular Medicine business Major bleeding medicine.drug Factor Xa Inhibitors
Zdroj:	Journal of cardiovascular pharmacology. 77(2)
ISSN:	1533-4023
Popis:	Direct oral anticoagulants (DOACs) have proven efficacy to prevent cardioembolic strokes. Data are scarce about the appropriateness of DOAC dosing in the Middle East. We investigated the prevalence of inappropriate DOAC dosing in the region. A cross-sectional study was conducted at our hospital between April 2015 and February 2019 of patients receiving 1 of the 3 available DOACs. Patients with incomplete data sets, those prescribed DOACs for indications other than atrial fibrillation, on DOACs for
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f88544f62404ff1d20706967f5132f https://pubmed.ncbi.nlm.nih.gov/32925474 Zobrazit plný text záznamu